These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9869486)

  • 1. Myocardial viability: seeking relevance and redefinition.
    Arrighi JA; Soufer R
    J Nucl Cardiol; 1998; 5(6):629-33. PubMed ID: 9869486
    [No Abstract]   [Full Text] [Related]  

  • 2. Steps forward in the assessment of myocardial viability in left ventricular dysfunction.
    Udelson JE
    Circulation; 1998 Mar; 97(9):833-8. PubMed ID: 9521330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical usefulness of positron emission tomography (PET) in the evaluation of myocardial viability].
    Coma-Canella I; García Velloso MJ
    Rev Esp Cardiol; 1997 Sep; 50(9):605-11. PubMed ID: 9380930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function.
    Beanlands RS; deKemp RA; Smith S; Johansen H; Ruddy TD
    Am J Cardiol; 1997 Apr; 79(8):1092-5. PubMed ID: 9114769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
    Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
    J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography for the assessment of myocardial viability: a synopsis of methods and indications.
    Lucignani G; Landoni C; Paolini G; Messa MC; Gilardi MC; Rossetti C; Fazio F
    Rays; 1999; 24(1):81-95. PubMed ID: 10358386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
    Schöder H; Campisi R; Ohtake T; Hoh CK; Moon DH; Czernin J; Schelbert HR
    J Am Coll Cardiol; 1999 Apr; 33(5):1328-37. PubMed ID: 10193735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
    Srinivasan G; Kitsiou AN; Bacharach SL; Bartlett ML; Miller-Davis C; Dilsizian V
    Circulation; 1998 Mar; 97(9):843-50. PubMed ID: 9521332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
    Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS;
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
    Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
    Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-modality imaging for assessment of myocardial viability?
    Reyes E
    Int J Cardiovasc Imaging; 2007 Dec; 23(6):767-70. PubMed ID: 17588163
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction.
    Rohatgi R; Epstein S; Henriquez J; Ababneh AA; Hickey KT; Pinsky D; Akinboboye O; Bergmann SR
    Am J Cardiol; 2001 May; 87(9):1096-9, A6. PubMed ID: 11348609
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial viability: contractile reserve or cell membrane integrity?
    Dilsizian V
    J Am Coll Cardiol; 1996 Aug; 28(2):443-6. PubMed ID: 8800123
    [No Abstract]   [Full Text] [Related]  

  • 16. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization.
    Kitsiou AN; Bacharach SL; Bartlett ML; Srinivasan G; Summers RM; Quyyumi AA; Dilsizian V
    J Am Coll Cardiol; 1999 Mar; 33(3):678-86. PubMed ID: 10080468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial tissue vitality: clinical relevance, pathophysiology and identification].
    Bax JJ; Cornel JH; Poldermans D; van Eck-Smit BL; van der Wall EE
    Ned Tijdschr Geneeskd; 1998 Jan; 142(2):67-71. PubMed ID: 9556996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?
    Bourque JM; Velazquez EJ; Borges-Neto S; Shaw LK; Whellan DJ; O'Connor CM
    Am Heart J; 2003 May; 145(5):758-67. PubMed ID: 12766731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hibernation and myocardial ischemia: clinical detection by positron emission tomography.
    Uren NG; Camici PG
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):273-9. PubMed ID: 1637733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability.
    Gerber BL; Ordoubadi FF; Wijns W; Vanoverschelde JL; Knuuti MJ; Janier M; Melon P; Blanksma PK; Bol A; Bax JJ; Melin JA; Camici PG
    Eur Heart J; 2001 Sep; 22(18):1691-701. PubMed ID: 11511119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.